Remove 2020 Remove BioTech Remove Health Policy Remove Telehealth
article thumbnail

The Healthcare and Macro-Economic Impacts of Living with Endemic COVID – Listening to Fitch

Health Populi

The last point on “new technologies” begs the question, “who” will fund innovation in health care as we emerge from the pandemic with national economics growing back at different paces, and employment in a very different context than pre-pandemic.

BioTech 270
article thumbnail

Value-Based Health Care Needs All Stakeholders at the Table – Especially the Patient

Health Populi

The coolest thing in health policy in the 21st century!! ” Amitabh Chandra gave the opening context-setting talk about the effects of health care cost-sharing on patients-as-consumers. have struggled to pay for living expenses since December 2020, a year into the COVID-19 pandemic.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

A Public Health Wake-Up Call: Reading Between the Lines in IQVIA’s 2023 Use of Medicines Report

Health Populi

First, we look at the macro picture on health services utilization comparing the end of 2022 with pre-COVID-19 levels. With an Index of 100 for the first 8 weeks of 2020 (that is, the 2 months before COVID-19 emerged in the U.S.),

article thumbnail

Americans Across Political Party Worry About Prescription Drug Prices – Especially to Deal with COVID-19

Health Populi

The Gallup-West Health Poll finds similar massive support for government negotiation specifically for COVID-19 treatment pricing, shown in the third table. Gallup and West Health polled 1,016 U.S. adults 18 and older, in English and Spanish, in May 2020. CMS defines specialty drugs as therapies with monthly costs over $670.

BioTech 191